scispace - formally typeset
C

Christine Wennerås

Researcher at Sahlgrenska University Hospital

Publications -  95
Citations -  3945

Christine Wennerås is an academic researcher from Sahlgrenska University Hospital. The author has contributed to research in topics: Enterotoxigenic Escherichia coli & Eosinophil. The author has an hindex of 28, co-authored 82 publications receiving 3461 citations. Previous affiliations of Christine Wennerås include University of Gothenburg.

Papers
More filters
Journal ArticleDOI

Nepotism and sexism in peer-review

TL;DR: In the first-ever analysis of peer-review scores for postdoctoral fellowship applications, the system is revealed as being riddled with prejudice.
Journal ArticleDOI

Prevalence of enterotoxigenic Escherichia coli-associated diarrhoea and carrier state in the developing world.

TL;DR: It is concluded that enterotoxigenic Escherichia coli remains an important diarrhoeal pathogen among children in the developing world.
Journal ArticleDOI

First Case of Human “Candidatus Neoehrlichia mikurensis” Infection in a Febrile Patient with Chronic Lymphocytic Leukemia

TL;DR: This work reports the first case of human disease caused by “Ca. Neoehrlichia mikurensis,” an immunocompromised patient presented with febrile episodes, an erysipelas-like rash, and thromboembolic complications.
Journal ArticleDOI

Cyclosporin H, Boc-MLF and Boc-FLFLF are Antagonists that Preferentially Inhibit Activity Triggered Through the Formyl Peptide Receptor

TL;DR: To determine FPR- and FPRL1-specific interactions, these antagonists should not be used at used at concentrations above 10 μM, and using cyclosporin H as a specific inhibitor for FPR is suggested.
Journal ArticleDOI

Increased levels of inflammatory mediators in children and adults infected with Vibrio cholerae O1 and O139.

TL;DR: Elevated concentrations of Lf, MPO, PGE2, LTB4, and NO·, as well as other metabolites, during the acute stage of the disease indicate that the innate defense system, aswell as the inflammatory process, is activated in both adults and pediatric patients infected with V. cholerae O1 and O139.